Boston Scientific (BSX) Gets a Hold from Erste Group
In a report released yesterday, Hans Engel from Erste Group assigned a Hold rating to Boston Scientific. The company’s shares closed today at $62.00.
End of Quarter Sale - 50% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Engel is a 4-star analyst with an average return of 8.5% and a 53.70% success rate. Engel covers the Technology sector, focusing on stocks such as Cisco Systems, International Business Machines, and Broadcom.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Boston Scientific with a $103.95 average price target, which is a 67.66% upside from current levels. In a report released on March 31, TipRanks – OpenAI also downgraded the stock to a Hold with a $69.00 price target.
Based on Boston Scientific’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $5.29 billion and a net profit of $668 million. In comparison, last year the company earned a revenue of $4.56 billion and had a net profit of $566 million
Read More on BSX:
Disclaimer & DisclosureReport an Issue
- Boston Scientific Investors File Lawsuit Over Alleged Misleading Statements About Electrophysiology Business Growth
- AI Models Turn More Positive on Boston Scientific, But Weak Technicals Temper Enthusiasm
- FTC issued Second Request to Penumbra, Boston Scientific over merger review
- Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
- Boston Scientific upside scenario unlikely after data, says Wells Fargo
